Effect of liberal glucose control on critically ill patients: a systematic review and meta-analysis

Most current guideline statements support some level of unrestricted glycemic management in critically ill adult patients. Nevertheless, the effectiveness of liberal glucose control is currently not well-supported by evidence. Therefore, our objective is to investigate the influence of liberal glucose control (> 180 mg/dl) on critically ill patients in the intensive care unit (ICU). Until November 23, 2023, English language literature was thoroughly and systematically searched through multiple databases, including PubMed, Embase, Cochrane Library, and Web of Science. Our primary endpoints of interest were the occurrence of hypoglycemia, mortality in the ICU, and mortality during hospitalization. In addition, our secondary outcomes comprised of 90-day mortality, bloodstream infections, the proportion of patients necessitating renal replacement therapy (RRT), the length of time under mechanical ventilation, duration of stay in the ICU, and length of the overall hospitalization. Weighted mean difference (WMD) and relative risk (RR) were respectively computed as overall effect size for continuous and dichotomous data and reported with their 95% confidence intervals (95% CI). A total of 9 studies were incorporated, which included 14,878 patients in the ICU. Compared with other blood glucose target control groups, liberal glucose control significantly reduced the incidence of hypoglycemia (RR = 0.41; 95% CI:0.25 to 0.69; P = 0.001), but increased ICU mortality (RR = 1.23; 95% CI:1.03 to 1.48; P = 0.023), in-hospital mortality risk (RR = 1.18; 95% CI:1.03 to 1.35; P = 0.020), and the risk of requiring RRT (RR = 1.26; 95% CI:1.11 to1.42; P < 0.001). Liberal glucose control can reduce the risk of hypoglycemia but increases the risks of ICU mortality, in-hospital mortality, and the requirement for RRT. To confirm the outcomes further, large-scale, high-quality clinical trials are necessary.

• Publication year

  2025

• Venue

  BMC Endocrine Disorders

• Publication date

  2025-02-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1186/s12902-025-01864-wPMID 39934786PMCID 11817051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Society of Critical Care Medicine Guidelines on Glycemic Control for Critically Ill Children and Adults 2024

  2024cited by this paper
• Tight Blood-Glucose Control without Early Parenteral Nutrition in the ICU.

  2023influential reference
• The Effect of a Liberal Approach to Glucose Control in Critically Ill Patients with Type 2 Diabetes: A multicenter, parallel-group, open-label, randomized clinical trial.

  2022influential reference
• Glycemic lability index and mortality in critically ill patients—A multicenter cohort study

  2021cited by this paper
• Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis

  2020influential reference
• Hyperglycemia in Medically Critically Ill Patients: Risk Factors and Clinical Outcomes.

  2020cited by this paper
• The Interaction of Acute and Chronic Glycemia on the Relationship of Hyperglycemia, Hypoglycemia, and Glucose Variability to Mortality in the Critically Ill.

  2020cited by this paper
• The Long and Winding Road to Personalized Glycemic Control in the Intensive Care Unit

  2019cited by this paper
• Hospital‐acquired complications in intensive care unit patients with diabetes: A before‐and‐after study of a conventional versus liberal glucose control protocol

  2019cited by this paper
• Documented hypoglycemia is associated with poor short and long term prognosis among patients admitted to general internal medicine departments.

  2019cited by this paper
• RoB 2: a revised tool for assessing risk of bias in randomised trials

  2019cited by this paper
• Liberal Glucose Control in ICU Patients With Diabetes: A Before-and-After Study*

  2018cited by this paper
• Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030

  2018influential reference
• The optimal target for acute glycemic control in critically ill patients: a network meta-analysis

  2016cited by this paper
• Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials

  2016cited by this paper
• Liberal Versus Conventional Glucose Targets in Critically Ill Diabetic Patients: An Exploratory Safety Cohort Assessment

  2016cited by this paper
• Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study

  2016influential reference
• The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

  2015cited by this paper
• Prevalence and Impact of Unknown Diabetes in the ICU

  2015cited by this paper
• Intensive Insulin Therapy for Septic Patients: A Meta-Analysis of Randomized Controlled Trials

  2014cited by this paper
• Inpatient Glycemic Control

  2014cited by this paper
• Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012

  2013cited by this paper
• Hypoglycemia and risk of death in critically ill patients.

  2012cited by this paper
• Mild hypoglycemia is independently associated with increased mortality in the critically ill

  2011cited by this paper
• Update on inpatient glycemic control in hospitals in the United States.

  2011cited by this paper
• Hypoglycemia is associated with intensive care unit mortality*

  2010cited by this paper
• Does intensive insulin therapy really reduce mortality in critically ill surgical patients? A reanalysis of meta-analytic data

  2010cited by this paper
• Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data

  2009cited by this paper
• Intensive versus conventional glucose control in critically ill patients.

  2009cited by this paper
• Glycemic variability: A strong independent predictor of mortality in critically ill patients*

  2008cited by this paper
• Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial

  2008cited by this paper
• Intensive insulin therapy and pentastarch resuscitation in severe sepsis.

  2008cited by this paper
• Benefits and risks of tight glucose control in critically ill adults: a meta-analysis.

  2008cited by this paper
• Intensive insulin therapy in the medical ICU.

  2006influential reference
• Cortisol response to critical illness: effect of intensive insulin therapy.

  2006influential reference
• Management of diabetes and hyperglycemia in hospitals.

  2004cited by this paper
• Effect of an intensive glucose management protocol on the mortality of critically ill adult patients.

  2004cited by this paper
• Methodological index for non‐randomized studies (MINORS): development and validation of a new instrument

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

  2002cited by this paper
• Intensive insulin therapy in critically ill patients.

  2002influential reference
• Intensive insulin therapy in critically ill patients.

  2001cited by this paper

• The significance of glycemic variability in conjunction with lactate metabolism levels in the clinical assessment of neonatal hypoxic-ischemic encephalopathy

  2025cites this paper
• Comparison of efficacy of different glucose control strategies in critically ill adults: a network meta-analysis of randomized controlled trials.

  2025cites this paper